Expert panel discussion on on the use of palbociclib in endocrine-resistant breast cancer. Learn about the clinical trial and optimize treatment strategies.
Speakers : Dr. Srinivas K G , Dr. Abhaya Kumar S M ,Dr. Vishwanath S
Explore expert insights from Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja on the latest treatment strategies for relapsed/refractory adult B-cell ALL.
Speakers : Dr. Pawan Kumar Singh ,Dr. Roshan Dixit ,Dr. Manisha Jain ,Dr. Avruti Baweja
Renowned experts Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja discuss treatment goals for relapsed adult B-cell ALL, covering immunotherapy, targeted therapies,
Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Avriti Baveja
Learn about CAR T-cell therapy, bispecific antibodies, and personalized treatment strategies. Watch now for cutting-edge recommendations!
Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Avriti Baveja
Explore expert insights from Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja on Iontuzumab’s impact on CR/CRi rates and MRD negativity in leukemia.
Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Roshan Dikshit , Dr. Avriti Baveja
Explore the long-term survival outcomes of iontuzumab-treated patients in the INO-VATE trial with experts Dr. Pawan Kumar Singh, Dr. Roshan Dikshit, Dr. Manisha Jain, and Dr. Avriti Baveja.
Speakers : Dr. Pawan Kumar Singh , Dr. Manisha Jain , Dr. Roshan Dikshit , Dr. Avriti Baveja
1.
Cancer during young adulthood carries long-term mental toll, study finds
2.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
3.
Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
4.
Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.
5.
Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit
1.
Exploring New Treatment Strategies for Mantle Cell Lymphoma
2.
Essential Techniques in Oncology and Quality Improvement
3.
Molecular Matching for Complex Blood Disorders
4.
Risk Assessment of Reduced Hematopoietic Reserve During Chronic Systemic Stress
5.
Oncology Team Communication Training for Clinical Learners
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
Breast Cancer Awareness and Early Detection
3.
How Advances in Cancer Research Are Improving Treatment Options
4.
Hands-on Workshop: Hematology
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation